- In March 2020, Invacare had announced the launch of Invacare AVIVA FX Power Wheelchair. The AVIVA brand offers a distinct look and feel that promises best-in-class design, technology, and performance. The AVIVA FX Power Wheelchair will provide current front-wheel drive users with a high-performance chair that represents a significant advancement in front-wheel drive power mobility
Frequently Asked Questions
The market is segmented based on Segmentation, By Products (Stem Cell Lines, Instruments, Consumables and Kits), Application (Research Applications, Clinical Applications, Cell and Tissue Banking and Others), End User (Biotechnology and Pharmaceutical Companies, Research Institutes and Academic Institutes, Cell Banks and Tissue Banks, Hospital and Surgical Centers and Others), Distribution Channel (Direct Sales and Third Party Distributor) – Industry Trends and Forecast to 2031
.
The Global Stem Cell Manufacturing Market size was valued at USD 14.98 USD Billion in 2023.
The Global Stem Cell Manufacturing Market is projected to grow at a CAGR of 10.6% during the forecast period of 2024 to 2031.
The major players operating in the market include BD, Thermo Fisher Scientific , Merck KGaA, Organogenesis , Vericel Corporation, ANTEROGEN. CO. , and more as listed-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..